Transdermal Scopolamine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Transdermal Scopolamine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal Scopolamine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal Scopolamine Overall Market Size
2.1 Global Transdermal Scopolamine Market Size: 2022 VS 2030
2.2 Global Transdermal Scopolamine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Transdermal Scopolamine Sales: 2018-2030
3 Company Landscape
3.1 Top Transdermal Scopolamine Players in Global Market
3.2 Top Global Transdermal Scopolamine Companies Ranked by Revenue
3.3 Global Transdermal Scopolamine Revenue by Companies
3.4 Global Transdermal Scopolamine Sales by Companies
3.5 Global Transdermal Scopolamine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transdermal Scopolamine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transdermal Scopolamine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal Scopolamine Players in Global Market
3.8.1 List of Global Tier 1 Transdermal Scopolamine Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal Scopolamine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Transdermal Scopolamine Market Size Markets, 2022 & 2030
4.1.2 Tablet Type
4.1.3 Syrups Type
4.1.4 Injections Type
4.1.5 Patch Type
4.1.6 Gel Type
4.2 By Type - Global Transdermal Scopolamine Revenue & Forecasts
4.2.1 By Type - Global Transdermal Scopolamine Revenue, 2018-2023
4.2.2 By Type - Global Transdermal Scopolamine Revenue, 2024-2030
4.2.3 By Type - Global Transdermal Scopolamine Revenue Market Share, 2018-2030
4.3 By Type - Global Transdermal Scopolamine Sales & Forecasts
4.3.1 By Type - Global Transdermal Scopolamine Sales, 2018-2023
4.3.2 By Type - Global Transdermal Scopolamine Sales, 2024-2030
4.3.3 By Type - Global Transdermal Scopolamine Sales Market Share, 2018-2030
4.4 By Type - Global Transdermal Scopolamine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transdermal Scopolamine Market Size, 2022 & 2030
5.1.2 Narcotic Analgesia
5.1.3 Cough
5.1.4 Asthma
5.1.5 Motion Sickness
5.1.6 Parkinson's Disease
5.1.7 Others
5.2 By Application - Global Transdermal Scopolamine Revenue & Forecasts
5.2.1 By Application - Global Transdermal Scopolamine Revenue, 2018-2023
5.2.2 By Application - Global Transdermal Scopolamine Revenue, 2024-2030
5.2.3 By Application - Global Transdermal Scopolamine Revenue Market Share, 2018-2030
5.3 By Application - Global Transdermal Scopolamine Sales & Forecasts
5.3.1 By Application - Global Transdermal Scopolamine Sales, 2018-2023
5.3.2 By Application - Global Transdermal Scopolamine Sales, 2024-2030
5.3.3 By Application - Global Transdermal Scopolamine Sales Market Share, 2018-2030
5.4 By Application - Global Transdermal Scopolamine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Transdermal Scopolamine Market Size, 2022 & 2030
6.2 By Region - Global Transdermal Scopolamine Revenue & Forecasts
6.2.1 By Region - Global Transdermal Scopolamine Revenue, 2018-2023
6.2.2 By Region - Global Transdermal Scopolamine Revenue, 2024-2030
6.2.3 By Region - Global Transdermal Scopolamine Revenue Market Share, 2018-2030
6.3 By Region - Global Transdermal Scopolamine Sales & Forecasts
6.3.1 By Region - Global Transdermal Scopolamine Sales, 2018-2023
6.3.2 By Region - Global Transdermal Scopolamine Sales, 2024-2030
6.3.3 By Region - Global Transdermal Scopolamine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Transdermal Scopolamine Revenue, 2018-2030
6.4.2 By Country - North America Transdermal Scopolamine Sales, 2018-2030
6.4.3 US Transdermal Scopolamine Market Size, 2018-2030
6.4.4 Canada Transdermal Scopolamine Market Size, 2018-2030
6.4.5 Mexico Transdermal Scopolamine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Transdermal Scopolamine Revenue, 2018-2030
6.5.2 By Country - Europe Transdermal Scopolamine Sales, 2018-2030
6.5.3 Germany Transdermal Scopolamine Market Size, 2018-2030
6.5.4 France Transdermal Scopolamine Market Size, 2018-2030
6.5.5 U.K. Transdermal Scopolamine Market Size, 2018-2030
6.5.6 Italy Transdermal Scopolamine Market Size, 2018-2030
6.5.7 Russia Transdermal Scopolamine Market Size, 2018-2030
6.5.8 Nordic Countries Transdermal Scopolamine Market Size, 2018-2030
6.5.9 Benelux Transdermal Scopolamine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Transdermal Scopolamine Revenue, 2018-2030
6.6.2 By Region - Asia Transdermal Scopolamine Sales, 2018-2030
6.6.3 China Transdermal Scopolamine Market Size, 2018-2030
6.6.4 Japan Transdermal Scopolamine Market Size, 2018-2030
6.6.5 South Korea Transdermal Scopolamine Market Size, 2018-2030
6.6.6 Southeast Asia Transdermal Scopolamine Market Size, 2018-2030
6.6.7 India Transdermal Scopolamine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Transdermal Scopolamine Revenue, 2018-2030
6.7.2 By Country - South America Transdermal Scopolamine Sales, 2018-2030
6.7.3 Brazil Transdermal Scopolamine Market Size, 2018-2030
6.7.4 Argentina Transdermal Scopolamine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Transdermal Scopolamine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Transdermal Scopolamine Sales, 2018-2030
6.8.3 Turkey Transdermal Scopolamine Market Size, 2018-2030
6.8.4 Israel Transdermal Scopolamine Market Size, 2018-2030
6.8.5 Saudi Arabia Transdermal Scopolamine Market Size, 2018-2030
6.8.6 UAE Transdermal Scopolamine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Baxter International
7.1.1 Baxter International Company Summary
7.1.2 Baxter International Business Overview
7.1.3 Baxter International Transdermal Scopolamine Major Product Offerings
7.1.4 Baxter International Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.1.5 Baxter International Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Transdermal Scopolamine Major Product Offerings
7.2.4 GlaxoSmithKline Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Transdermal Scopolamine Major Product Offerings
7.3.4 Novartis AG Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Perrigo Company
7.4.1 Perrigo Company Company Summary
7.4.2 Perrigo Company Business Overview
7.4.3 Perrigo Company Transdermal Scopolamine Major Product Offerings
7.4.4 Perrigo Company Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.4.5 Perrigo Company Key News & Latest Developments
7.5 Caleb Pharmaceuticals
7.5.1 Caleb Pharmaceuticals Company Summary
7.5.2 Caleb Pharmaceuticals Business Overview
7.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Major Product Offerings
7.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.5.5 Caleb Pharmaceuticals Key News & Latest Developments
7.6 Myungmoon Pharma
7.6.1 Myungmoon Pharma Company Summary
7.6.2 Myungmoon Pharma Business Overview
7.6.3 Myungmoon Pharma Transdermal Scopolamine Major Product Offerings
7.6.4 Myungmoon Pharma Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.6.5 Myungmoon Pharma Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Transdermal Scopolamine Major Product Offerings
7.7.4 Pfizer Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Nichi-Iko
7.8.1 Nichi-Iko Company Summary
7.8.2 Nichi-Iko Business Overview
7.8.3 Nichi-Iko Transdermal Scopolamine Major Product Offerings
7.8.4 Nichi-Iko Transdermal Scopolamine Sales and Revenue in Global (2018-2023)
7.8.5 Nichi-Iko Key News & Latest Developments
8 Global Transdermal Scopolamine Production Capacity, Analysis
8.1 Global Transdermal Scopolamine Production Capacity, 2018-2030
8.2 Transdermal Scopolamine Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal Scopolamine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal Scopolamine Supply Chain Analysis
10.1 Transdermal Scopolamine Industry Value Chain
10.2 Transdermal Scopolamine Upstream Market
10.3 Transdermal Scopolamine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal Scopolamine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Transdermal Scopolamine in Global Market
Table 2. Top Transdermal Scopolamine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Transdermal Scopolamine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Transdermal Scopolamine Revenue Share by Companies, 2018-2023
Table 5. Global Transdermal Scopolamine Sales by Companies, (K Units), 2018-2023
Table 6. Global Transdermal Scopolamine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Transdermal Scopolamine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Transdermal Scopolamine Product Type
Table 9. List of Global Tier 1 Transdermal Scopolamine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal Scopolamine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Transdermal Scopolamine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Transdermal Scopolamine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Transdermal Scopolamine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Transdermal Scopolamine Sales (K Units), 2018-2023
Table 15. By Type - Global Transdermal Scopolamine Sales (K Units), 2024-2030
Table 16. By Application ? Global Transdermal Scopolamine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Transdermal Scopolamine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Transdermal Scopolamine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Transdermal Scopolamine Sales (K Units), 2018-2023
Table 20. By Application - Global Transdermal Scopolamine Sales (K Units), 2024-2030
Table 21. By Region ? Global Transdermal Scopolamine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Transdermal Scopolamine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Transdermal Scopolamine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Transdermal Scopolamine Sales (K Units), 2018-2023
Table 25. By Region - Global Transdermal Scopolamine Sales (K Units), 2024-2030
Table 26. By Country - North America Transdermal Scopolamine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Transdermal Scopolamine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Transdermal Scopolamine Sales, (K Units), 2018-2023
Table 29. By Country - North America Transdermal Scopolamine Sales, (K Units), 2024-2030
Table 30. By Country - Europe Transdermal Scopolamine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Transdermal Scopolamine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Transdermal Scopolamine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Transdermal Scopolamine Sales, (K Units), 2024-2030
Table 34. By Region - Asia Transdermal Scopolamine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Transdermal Scopolamine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Transdermal Scopolamine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Transdermal Scopolamine Sales, (K Units), 2024-2030
Table 38. By Country - South America Transdermal Scopolamine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Transdermal Scopolamine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Transdermal Scopolamine Sales, (K Units), 2018-2023
Table 41. By Country - South America Transdermal Scopolamine Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Transdermal Scopolamine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Transdermal Scopolamine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Transdermal Scopolamine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Transdermal Scopolamine Sales, (K Units), 2024-2030
Table 46. Baxter International Company Summary
Table 47. Baxter International Transdermal Scopolamine Product Offerings
Table 48. Baxter International Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Baxter International Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Transdermal Scopolamine Product Offerings
Table 52. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Transdermal Scopolamine Product Offerings
Table 56. Novartis AG Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Perrigo Company Company Summary
Table 59. Perrigo Company Transdermal Scopolamine Product Offerings
Table 60. Perrigo Company Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Perrigo Company Key News & Latest Developments
Table 62. Caleb Pharmaceuticals Company Summary
Table 63. Caleb Pharmaceuticals Transdermal Scopolamine Product Offerings
Table 64. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Caleb Pharmaceuticals Key News & Latest Developments
Table 66. Myungmoon Pharma Company Summary
Table 67. Myungmoon Pharma Transdermal Scopolamine Product Offerings
Table 68. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Myungmoon Pharma Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Transdermal Scopolamine Product Offerings
Table 72. Pfizer Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Nichi-Iko Company Summary
Table 75. Nichi-Iko Transdermal Scopolamine Product Offerings
Table 76. Nichi-Iko Transdermal Scopolamine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Nichi-Iko Key News & Latest Developments
Table 78. Transdermal Scopolamine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Transdermal Scopolamine Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Transdermal Scopolamine Production by Region, 2018-2023 (K Units)
Table 81. Global Transdermal Scopolamine Production by Region, 2024-2030 (K Units)
Table 82. Transdermal Scopolamine Market Opportunities & Trends in Global Market
Table 83. Transdermal Scopolamine Market Drivers in Global Market
Table 84. Transdermal Scopolamine Market Restraints in Global Market
Table 85. Transdermal Scopolamine Raw Materials
Table 86. Transdermal Scopolamine Raw Materials Suppliers in Global Market
Table 87. Typical Transdermal Scopolamine Downstream
Table 88. Transdermal Scopolamine Downstream Clients in Global Market
Table 89. Transdermal Scopolamine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Transdermal Scopolamine Segment by Type in 2022
Figure 2. Transdermal Scopolamine Segment by Application in 2022
Figure 3. Global Transdermal Scopolamine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transdermal Scopolamine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Transdermal Scopolamine Revenue, 2018-2030 (US$, Mn)
Figure 7. Transdermal Scopolamine Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Transdermal Scopolamine Revenue in 2022
Figure 9. By Type - Global Transdermal Scopolamine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 12. By Type - Global Transdermal Scopolamine Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Transdermal Scopolamine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 16. By Application - Global Transdermal Scopolamine Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Transdermal Scopolamine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Transdermal Scopolamine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 21. By Country - North America Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 23. US Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 28. Germany Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 29. France Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 37. China Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 41. India Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 44. Brazil Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Transdermal Scopolamine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Transdermal Scopolamine Sales Market Share, 2018-2030
Figure 48. Turkey Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Transdermal Scopolamine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Transdermal Scopolamine Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Transdermal Scopolamine by Region, 2022 VS 2030
Figure 54. Transdermal Scopolamine Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
